Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab
Rogatsch, Max
•
Schmid, Johannes
•
Lax, Sigurd
altro
2018
Periodico
EUROPEAN JOURNAL OF CANCER
Abstract
nessun abstract
DOI
WOS
Archivio
Diritti
open access
license:digital rights management non definito
license:creative commons
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
FVG url
Soggetti